Larvol Delta - Ankyra-Announces-Publication-of-Phase-1-Clinical-Data-and-Will-Present-at-the-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting

ANK-201 - Ankyra Therap

tolododekin alfa (ANK-101) - Ankyra Therap

https://www.businesswire.com/news/home/20251104335799/en/Ankyra-Announces-Publication-of-Phase-1-Clinical-Data-and-Will-Present-at-the-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting

Nov 4, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next